by Natalie Harper | Jun 18, 2025 | Blog, Home Office
As described in the Misuse of Drugs Act 1971 and the Misuse of Drugs Regulations (MDR) 2001, any company wishing to possess, manufacture, produce or supply controlled drugs in England, Wales or Scotland will need to apply for a domestic licence – this includes where you are not physically handling but are directing and / or taking ownership.
by Claire Dugdale | Jun 16, 2025 | Blog, MHRA
FSN (Field Safety Notice) for Zoll Powerheart G5 AEDs was issued by Zoll earlier this year for G5 AEDs that may display Error Code (EC) 501.
by Natalie Harper | Jun 13, 2025 | Blog, MHRA, WDA(H)
It is common in today’s rapidly evolving pharmaceutical sector that companies need to outsource key activities. This can be for a number of reasons including specialist expertise, specialist storage facilities, capacity of both facilities and people, cost to your organisation and time.
by Kimberley Peck | Jun 5, 2025 | Blog, Pharmacy
There have been several Pharmacy Regulatory changes which will come into force on the 23rd June 2025. Are you ready for them? Firstly, the market entry for Distance Selling models is closing, if you are contemplating a Distance Selling Pharmacy, the application must...
by Kimberley Peck | Jun 4, 2025 | Blog, Distance Selling Pharmacy, Pharmacy
The market entry process for distance selling pharmacies is closing on 23rd June 2025. Having been laid before parliament on the 2nd of June changes to the community pharmacy sector will come into force in 21 days.
by Natalie Harper | Jun 3, 2025 | Blog, Good Distribution Practice - GDP, MHRA, WDA(H)
It is common in today’s rapidly evolving pharmaceutical sector that companies need to outsource key activities. This can be for several reasons including specialist expertise, specialist storage facilities, capacity of both facilities and people, cost to your organisation and time.